Acumen Pharmaceuticals, Inc. (ABOS) — 分析师展望 / 分析师共识目标价为. 基于 7 位分析师评级, 共识为 看涨 — 7 买入.
分析师共识目标价为 $7.00, 上涨空间为 161.2% 相对于当前价格 $2.68.
分析师预估 每股收益(EPS)为 $-1.60 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.71 vs 预期 $-1.60 (不及预期 -6.6%). 2025: 实际 $-2.00 vs 预期 $-2.05 (超预期 +2.3%). 分析师准确度: 96%.
ABOS 股票 — 12个月价格预测
$7.00
▲ +161.19% 上涨空间
平均目标价
Based on 7 Wall Street analysts offering 12-month price targets for Acumen Pharmaceuticals, Inc., the price target is $7.00.
平均目标价相对最新价格 $2.68 变动 +161.19%。
ABOS 分析师评级
Buy
基于过去3个月内 7 位分析师对 Acumen Pharmaceuticals, Inc. 的评级
EPS 预测 — ABOS
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.71
vs Est –$1.60
▼ 6.2% off
2025
Actual –$2.00
vs Est –$2.05
▲ 2.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — ABOS
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
